Literature DB >> 21689244

Alopecia areata: Clinical presentation, diagnosis, and unusual cases.

Andreas M Finner1.   

Abstract

Alopecia areata (AA) is a nonscarring hair loss disorder with a 2% lifetime risk. Most patients are below 30 years old. Clinical types include patchy AA, AA reticularis, diffuse AA, AA ophiasis, AA sisiapho, and perinevoid AA. Besides scalp and body hair, the eyebrows, eyelashes, and nails can be affected. The disorder may be circumscribed, total (scalp hair loss), and universal (loss of all hairs). Atopy, autoimmune thyroid disease, and vitiligo are more commonly associated. The course of the disease is unpredictable. However, early, long-lasting, and severe cases have a less favorable prognosis. The clinical diagnosis is made by the aspect of hairless patches with a normal skin and preserved follicular ostia. Exclamations mark hairs and a positive pull test signal activity. Dermoscopy may reveal yellow dots. White hairs may be spared; initial regrowth may also be nonpigmented. The differential diagnosis includes trichotillomania, scarring alopecia, and other nonscarring hair loss disorders such as tinea capitis and syphilis.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21689244     DOI: 10.1111/j.1529-8019.2011.01413.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  28 in total

Review 1.  Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.

Authors:  Ralph M Trüeb; Maria Fernanda Reis Gavazzoni Dias
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.

Authors:  A Sterkens; J Lambert; A Bervoets
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

Review 3.  Alopecia areata: Part 1: pathogenesis, diagnosis, and prognosis.

Authors:  Frank Spano; Jeff C Donovan
Journal:  Can Fam Physician       Date:  2015-09       Impact factor: 3.275

4.  Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis.

Authors:  Solam Lee; Beom Jun Kim; Chung-Hyeok Lee; Won-Soo Lee
Journal:  JAMA Dermatol       Date:  2019-05-01       Impact factor: 10.282

Review 5.  Alopecia areata.

Authors:  C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg
Journal:  Nat Rev Dis Primers       Date:  2017-03-16       Impact factor: 52.329

Review 6.  Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point.

Authors:  Bo Xie; Jiayi Sun; Xiuzu Song
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-19       Impact factor: 10.817

Review 7.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

8.  Vitiligo and alopecia areata: apples and oranges?

Authors:  John E Harris
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

Review 9.  Female Pattern Hair Loss: a clinical and pathophysiological review.

Authors:  Paulo Müller Ramos; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

10.  Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.

Authors:  Ali Jabbari; Zhenpeng Dai; Luzhou Xing; Jane E Cerise; Yuval Ramot; Yackov Berkun; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky; Angela M Christiano; Raphael Clynes; Abraham Zlotogorski
Journal:  EBioMedicine       Date:  2015-02-26       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.